TARA MORRIS: Open Payments
NPI 1013950674 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,772 in 70 payments from 26 companies in 2025. Trend: 2023 $1,619 · 2024 $1,531 · 2025 $1,772
Food & beverage: $1,772
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 7 | $273 |
| UCB, Inc. | 10 | $245 |
| Biogen, Inc. | 7 | $239 |
| Amgen Inc. | 9 | $136 |
| Lundbeck LLC | 4 | $101 |
| Alnylam Pharmaceuticals Inc. | 3 | $88 |
| ARGENX US, INC. | 3 | $71 |
| CSL Behring | 3 | $71 |
| ABBVIE INC. | 2 | $59 |
| Neurelis, Inc. | 3 | $57 |
Products named: TYSABRI, Rystiggo, UPLIZNA, AMVUTTRA, VYEPTI, Hizentra, VALTOCO, VYVGART HYTRULO.
Industry payments across MD — which companies pay providers there.
